YHLO showcased in Medica 2022
Everything was set in place! From 14 - 17 November 2022, the largest medical trade fair in the world - Medica, was in full swing!
On 14 November 2022, YHLO international team brought our key products - iFlash family (CLIA analyzers) and Vision series (ESR) together to show guests around the world the innovation capacity of Chinese companies and the high quality of Chinese products.
During the Fair, YHLO’s booth is packed to the gills. YHLO professional staff introduced the products to the guests patiently and professionally. During this time, our iFlash family aroused great interest and received great recognition from the customers. Every day we can receive a large number of customer business cards and inquiries.
Innovation has always been the key driving force of development for YHLO. In the past year, YHLO established the R&D center in Japan and keeps close cooperation with scientific research institutions all around the world. Up to now, more than 150 academic papers were published in 2022, and many of them have been published in academic journals with high-impact factors such as JAMA and Infection.
As one of the leading brands of CLIA from China, YHLO will insist on self-dependent innovation and continue to raise the capacity for innovation, to show the charm of Chinese brands to the world.
Attachments:
Previous Page
Next Page
MORE NEWS
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
2025-11-20
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
2025-11-18
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
